ORIGINAL RESEARCH article
Front. Pharmacol.
Sec. Pharmacoepidemiology
Volume 16 - 2025 | doi: 10.3389/fphar.2025.1700469
Drug-associated serotonin syndrome in elderly patients: a comprehensive disproportionality analysis based on the FAERS database
Provisionally accepted- 1Department of Medical Oncology, Cancer Hospital of Shantou University Medical College, Shantou, China
- 2Department of Pharmacy, The Second Affiliated Hospital of Shantou University Medical College, Shantou, China
- 3Department of Pharmacy, The Sixth Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China
- 4Department of Pharmacy, The Affiliated Hospital of Guizhou Medical University, Department of Pharmacy, Guizhou Hospital of The First Affiliated Hospital, Sun Yat-sen University, Guiyang, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background This study aims to identify drugs associated with serotonin syndrome in elderly patients by utilizing the FDA Adverse Event Reporting System (FAERS), to provide evidence-based references for safe clinical medication practices. Methods This study analyzed data extracted from the FAERS covering the period from Q1 2004 to Q1 2025, with the objective of identifying drugs associated with serotonin syndrome in elderly patients. Disproportionality analysis was utilized to detect potential drug-associated signals, and sensitivity analyses were performed to evaluate the stability and strength of serotonin syndrome signals associated with these drugs. Time-to-onset (TTO) analysis was conducted to investigate factors influencing the clinical presentation of serotonin syndrome. This is a provisional file, not the final typeset article Results Disproportionality analysis identified 68 drugs associated with serotonin syndrome in elderly patients. Among the drugs with positive signals, the most frequently reported category associated with serotonin syndrome in elderly patients was nervous system drugs, followed by antiinfectives for systemic use, alimentary tract and metabolism drugs, musculo-skeletal system drugs, dermatologicals, and respiratory system drugs. Sensitivity analyses confirmed that most positive signals remained robust. TTO analysis revealed that drug-associated serotonin syndrome onset occurred earlier in elderly female patients. Conclusions Drug-associated serotonin syndrome risk is elevated among elderly patients.Prompt identification and discontinuation of the causative drugs are crucial for the effective management of serotonin syndrome. In clinical practice, the risk of drug-associated serotonin syndrome should be taken into account to optimize pharmacotherapy.
Keywords: Elderly Patients1, Drug-Associated2, Serotonin syndrome3, pharmacovigilance4, FARES5, ADEs6
Received: 06 Sep 2025; Accepted: 10 Oct 2025.
Copyright: © 2025 Li, Wen, Fu, Hong, Lin, Li, Liang, Wang, Yu, Zhou and Luo. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Xiajiong Luo, luoxiajiong@163.com
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.